The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms
- PMID: 29593707
- PMCID: PMC5859047
- DOI: 10.3389/fimmu.2018.00302
The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms
Abstract
Background: The mechanisms underlying the non-antimicrobial immunomodulatory properties of macrolides are not well understood.
Objectives: To systematically review the evidence for the immunomodulatory properties of macrolides in humans and to describe the underlying mechanism and extent of their influence on the innate and adaptive immune system.
Methods: A systematic literature search was done in MEDLINE using the OVID interface from 1946 to December 2016 according to the preferred reporting items for systematic reviews and meta-analysis (PRISMA). Original articles investigating the influence of four macrolides (azithromycin, clarithromycin, erythromycin, and roxithromycin) on immunological markers in humans were included.
Results: We identified 22 randomized, controlled trials, 16 prospective cohort studies, and 8 case-control studies investigating 47 different immunological markers (186 measurements) in 1,834 participants. The most frequently reported outcomes were a decrease in the number of neutrophils, and the concentrations of neutrophil elastase, interleukin (IL)-8, IL-6, IL-1beta, tumor necrosis factor (TNF)-alpha, eosinophilic cationic protein, and matrix metalloproteinase 9. Inhibition of neutrophil function was reported more frequently than eosinophil function. A decrease in T helper (Th) 2 cells cytokines (IL-4, IL-5, IL-6) was reported more frequently than a decrease in Th1 cytokines (IL-2, INF-gamma).
Conclusion: Macrolides influence a broad range of immunological mechanisms resulting in immunomodulatory effects. To optimize the treatment of chronic inflammatory diseases by macrolides, further studies are necessary, particularly comparing different macrolides and dose effect relationships.
Keywords: azalides; azithromycin; clarithromycin; erythromycin; immunolides; roxithromycin.
Figures
Similar articles
-
Clinical implications of the immunomodulatory effects of macrolides.Am J Med. 2004 Nov 8;117 Suppl 9A:5S-11S. doi: 10.1016/j.amjmed.2004.07.023. Am J Med. 2004. PMID: 15586558 Review.
-
Immunomodulatory effects of macrolides: implications for practicing clinicians.Am J Med. 2004 Nov 8;117 Suppl 9A:26S-29S. doi: 10.1016/j.amjmed.2004.07.026. Am J Med. 2004. PMID: 15586561 Review.
-
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?J Antimicrob Chemother. 2005 Jan;55(1):10-21. doi: 10.1093/jac/dkh519. Epub 2004 Dec 8. J Antimicrob Chemother. 2005. PMID: 15590715 Review.
-
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.Eur J Clin Pharmacol. 2012 May;68(5):479-503. doi: 10.1007/s00228-011-1161-x. Epub 2011 Nov 22. Eur J Clin Pharmacol. 2012. PMID: 22105373 Review.
-
Approaches to the synthesis of immunolides: selective immunomodulatory macrolides for cystic fibrosis.Curr Opin Drug Discov Devel. 2005 Nov;8(6):741-7. Curr Opin Drug Discov Devel. 2005. PMID: 16312149 Review.
Cited by
-
Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against Mycobacterium avium infection but is ineffective as an adjunct to antibiotic treatment in chronic disease.Virulence. 2022 Dec;13(1):808-832. doi: 10.1080/21505594.2022.2068489. Virulence. 2022. PMID: 35499090 Free PMC article.
-
The Procalcitonin-guided Antibiotics in Respiratory Infections (PARI) project in general practice - a study protocol.BMC Prim Care. 2022 Mar 12;23(1):43. doi: 10.1186/s12875-022-01646-6. BMC Prim Care. 2022. PMID: 35279069 Free PMC article.
-
Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas.World J Gastrointest Oncol. 2022 Jan 15;14(1):153-162. doi: 10.4251/wjgo.v14.i1.153. World J Gastrointest Oncol. 2022. PMID: 35116108 Free PMC article. Review.
-
Clarithromycin impairs tissue-resident memory and Th17 responses to macrolide-resistant Streptococcus pneumoniae infections.J Mol Med (Berl). 2021 Jun;99(6):817-829. doi: 10.1007/s00109-021-02039-5. Epub 2021 Feb 17. J Mol Med (Berl). 2021. PMID: 33595670 Free PMC article.
-
Clinical characteristics and associated factors of macrolide-resistant mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis.Eur J Clin Microbiol Infect Dis. 2025 Jun;44(6):1505-1522. doi: 10.1007/s10096-025-05101-z. Epub 2025 Mar 19. Eur J Clin Microbiol Infect Dis. 2025. PMID: 40106136
References
-
- Piscitelli SC, Danziger LH, Rodvold KA. Clarithromycin and azithromycin: new macrolide antibiotics. Clin Pharm (1992) 11(2):137–52. - PubMed
-
- Retsema J, Girard A, Schelkly W, Manousos M, Anderson M, Bright G, et al. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother (1987) 31(12):1939–47.10.1128/AAC.31.12.1939 - DOI - PMC - PubMed
-
- Poliak MS. [Content of monomycin in bile and its effectiveness in inflammatory diseases and surgery of the biliary tract]. Antibiotiki (1963) 8:83–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical